Table 1.
Clinical and pathological characteristics of the patients
| Parameters | n (%) |
|---|---|
| Menopausal status | |
| Premenopausal | 217 (75.6) |
| Postmenopausal | 70 (24.4) |
| Tumor size (cm) | |
| ≤ 2 | 102 (35.5) |
| > 2 | 168 (58.5) |
| Unknown | 17 (5.9) |
| Lymph nodes | |
| Negative | 82 (28.6) |
| Positive | 199 (69.3) |
| Unknown | 6 (2.1) |
| Estrogen Receptor | |
| Negative | 36 (12.5) |
| Positive | 245 (85.4) |
| Unknown | 6 (2.1) |
| Progesterone Receptor | |
| Negative | 65 (22.6) |
| Positive | 216 (75.3) |
| Unknown | 6 (2.1) |
| HER-2 status | |
| Negative | 174 (60.6) |
| Positive | 70 (24.4) |
| Unknown | 43 (15.0) |
| BMI | |
| ≤ 24 | 159 (55.6) |
| > 24 | 128 (44.4) |
| Adjuvant hormone therapy | |
| Tamoxifen | 250 (87.1) |
| Aromatase inhibitors | 37 (12.9) |
| Adjuvant chemotherapy | |
| Yes | 274 (95.5) |
| No | 13 (4.5) |